Abbreviations
Classes
MoAs
Labs
First Line Treatment Options
200

TDF/TAF

Tenofovir (disoproxil fumarate and alafenamide)

200

Dolutegravir 

Integrase inhibitor (INSTI)

200

What drug class competitively inhibits the reverse transcriptase enzyme

NRTIs (gotta love the nukes)

200

Assesses overall immune status (a key cell in our immune system)

CD4 T-lymphocyte count (cells/mm3)

200

Which first line treatment options contain only two drugs?

Dovato (Dolutegravir/Lamivudine)


400

BIC

Bictegravir

400

Darunavir

Protease Inhibitor 

400

CYP3A4 inhibitor that is used as a "booster" in regimens

Cobicistat

400

Assesses effectiveness of HIV therapy; useful for disease progression, indirect adherence monitoring, and potential for treatment failure/resistance

HIV RNA - viral load (copies/mL)

400

Which first line treatment HIV drug needs HLA-B 5701 allele testing before use?

Triumeq (Dolutegravir/Abacavir/Lamivudine)

600

/r

Ritonavir

600

Triumeq 

Two NRTIs and an INSTI

600

This drug class inhibits the budding and maturation of the HIV virus. (hint: it inhibits an enzyme)

Protease Inhibitors 

600

This lab may be falsely low in patients living with HIV

A1c

600

At what CrCl would you not want to start Biktarvy?

CrCl <30 mL/min

800

FTC

Emtricitabine

800

Ritonavir (technically a part of two classes but which one do we mainly use it for)

Pharmacokinetic Booster

800

This drug class prevents HIV DNA from inserting into the host cell DNA

Integrase Inhibitors 

800

We test for this gene to determine if a patient can receive abacavir due to the risk of severe allergic reactions

HLA-B*5701

800

Name one side effect that can be seen with Biktegravir.

Weight gain (integrase inhibitors)

1000

DRV

Darunavir

1000

Symtuza (hint there are three drugs with a booster) 

Two NRTIs, PI, and cobicistat (booster)
1000

This medication non-competitively inhibits the reverse transcriptase enzyme and must be taken with food.

Rilpivirine

1000

Vitamin level that is commonly deficient in patients living with HIV

Vitamin D (<20 ng/mL indicates deficiency)

1000

Why would Genvoya be a poor option to use in a patient with seizures?

Contains Cobicistat (CYP3A4 inhibitor)